Last reviewed · How we verify
Acetate-free dialysis solution
Acetate-free dialysis solution is a Biologic drug developed by Chulalongkorn University. It is currently FDA-approved.
Acetate-free dialysis solution, developed by Chulalongkorn University, is a marketed product with a key composition patent expiring in 2028. The primary strength of this solution lies in its unique formulation, which may offer improved patient outcomes compared to traditional acetate-based solutions. The primary risk is the lack of significant revenue data, which could impact its market competitiveness and investment attractiveness.
At a glance
| Generic name | Acetate-free dialysis solution |
|---|---|
| Sponsor | Chulalongkorn University |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study of a Dialysate Without Acetate on Protein Energy Wasting Syndrome in Chronic Hemodialysis Patient (EASY) (NA)
- Hemodynamic and Respiratory Tolerance of Intermittent Hemodialysis in Critically Ill Patients
- Effects of Postdilution Online Hemodiafiltration With AcEtate-free Citrate dialySis Fluid on Inflammation Markers
- Strategies for Asymmetrical Triacetate Dialyzer Heparin-Free Effective Hemodialysis (PHASE2)
- The Effect of Citrate Dialysate on Clot Formation and Anemia in Hemodialysis Patients (NA)
- Calcium Mass Balance and Dialytic Efficiency of a New cITRate-containing and Acetate-free Dialysis flUidS: CITRUS Study
- Substitution of Acetate by Citrate in the Bicarbonate Based Hemodialysis (NA)
- Comparison of Cardiac Index and Cardiac Output Effect During Maintenance Hemodialysis Between Acetate-Free and Acetate-Based Online Hemodiafiltration (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Acetate-free dialysis solution CI brief — competitive landscape report
- Acetate-free dialysis solution updates RSS · CI watch RSS
- Chulalongkorn University portfolio CI
Frequently asked questions about Acetate-free dialysis solution
What is Acetate-free dialysis solution?
Who makes Acetate-free dialysis solution?
What development phase is Acetate-free dialysis solution in?
Related
- Manufacturer: Chulalongkorn University — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing